tirzepatide available (Zepbound) – A New Treatment for Obstructive Sleep Apnea and Obesity — BetterNight Tirzepatide - Wikipedia

Our remedies are methylated B vitamins

23, Novo Nordisk released late-stage study results showing participants who took its next-generation obesity drug, CagriSema, didnt lose quite as much weight (23%) as those who took rival Eli Lillys Zepbound (25.5%)

Patients should also be aware that rapid improvement in glucose control can transiently worsen diabetic retinopathy

Consequently, on top of the beneficial effect of weight loss caused by GLP-1 analogues these drugs also cause a substantial reduction of the glycemic load (GL = carbohydrate intake X Glycemic index), which per se reduces hyperinsulinemia and causes weight loss [22], reduce diabetes risk [23], inflammation [24], and cardiovascular risk [25]